| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1997;63:105-111
© 1997 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery, Ullevål Hospital, University of Oslo, Oslo, Norway
Accepted for publication July 16, 1996.
Background. The inflammatory response induced by cardiopulmonary bypass can result in severe organ dysfunction in some patients. This postperfusion response is caused mainly by contact between blood and the foreign surface of the cardiopulmonary bypass equipment and includes adhesion of leukocytes to vascular endothelium, which precedes a series of events that mediate inflammatory damage to tissues.
Methods. Low-risk patients accepted for coronary artery bypass grafting were randomized to operation with the cardiopulmonary bypass surface either completely heparin coated (Duraflo II) or uncoated. There were 12 patients in each group. Blood plasma sampled during cardiopulmonary bypass was analyzed for complement activation (C3bc and terminal SC5b-9 complement complex) and neutrophil activation (lactoferrin and myeloperoxidase). In addition, neutrophils, monocytes, and platelets were counted, and the expression of surface markers on the neutrophils and monocytes (complement receptor [CR] 1, CR3, CR4, and L-selectin) and on the platelets (P-selectin and CD41) was quantified with flow cytometry.
Results. Clinical and surgical results were similar in both groups. In the group with the heparin-coated surface, the formation of the terminal SC5b-9 complement complex was significantly reduced, and the counts of circulating leukocytes and platelets were significantly less reduced initially but were higher at the end of cardiopulmonary bypass compared with baseline. Also, the expression of CR1, CR3, and CR4 was significantly less upregulated and the L-selectin, significantly less downregulated on monocytes and neutrophils.
Conclusions. We conclude that heparin coating reduces complement activation and attenuates the leukocyte integrin and selectin response that occurs when uncoated circuits are used.
This article has been cited by other articles:
|
|
 |
|
  G. S. Murphy, E. A. Hessel II, and R. C. Groom Optimal Perfusion During Cardiopulmonary Bypass: An Evidence-Based Approach Anesth. Analg., May 1, 2009; 108(5): 1394 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Mangoush, S. Purkayastha, S. Haj-Yahia, J. Kinross, M. Hayward, F. Bartolozzi, A. Darzi, and T. Athanasiou Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1058 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Shann, D. S. Likosky, J. M. Murkin, R. A. Baker, Y. R. Baribeau, G. R. DeFoe, T. A. Dickinson, T. J. Gardner, H. P. Grocott, G. T. O'Connor, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 283 - 290.e3. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lindholm, M. Westerberg, A. Bengtsson, R. Ekroth, E. Jensen, and A. Jeppsson A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients Ann. Thorac. Surg., December 1, 2004; 78(6): 2131 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lund, P. K. Hol, R. Lundblad, E. Fosse, K. Sundet, B. Tennoe, R. Brucher, and D. Russell Reply Ann. Thorac. Surg., October 1, 2004; 78(4): 1514 - 1515. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Demirkilic, E. Kuralay, H. Tatar, M. Kocakulak, C. Kocum, and H. Ayhan Investigation of Blood Compatibility and Determination of Clinical Performance of PMEA Coated and Flow Optimized Oxygenator Journal of Bioactive and Compatible Polymers, September 1, 2004; 19(5): 395 - 408. [Abstract] [PDF]
|
|
|
|
 |
|
 T. N Hoel, V. Videm, S. T Baksaas, T. E Mollnes, F. Brosstad, and J. L Svennevig Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery Perfusion, May 1, 2004; 19(3): 177 - 184. [Abstract] [PDF]
|
|
|
|
|
|
T. Ikuta, H. Fujii, T. Shibata, K. Hattori, H. Hirai, H. Kumano, and S. Suehiro A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy Ann. Thorac. Surg., May 1, 2004; 77(5): 1678 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Palatianos, C. N. Foroulis, M. I. Vassili, G. Astras, K. Triantafillou, E. Papadakis, A. A. Lidoriki, E. Iliopoulou, and E. N. Melissari A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit Ann. Thorac. Surg., July 1, 2003; 76(1): 129 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kalawski, M. Majewski, E. Kaszkowiak, H. Wysocki, and T. Siminiak Transcardiac Release of Soluble Adhesion Molecules During Coronary Artery Bypass Grafting: Effects of Crystalloid and Blood Cardioplegia Chest, May 1, 2003; 123(5): 1355 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ninomiya, K. Miyaji, and S. Takamoto Influence of PMEA-coated bypass circuits on perioperative inflammatory response Ann. Thorac. Surg., March 1, 2003; 75(3): 913 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vijay and K. McCusker Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass Perfusion, January 1, 2003; 18(1_suppl): 41 - 45. [PDF]
|
|
|
|
|
|
M. Johnell, G. Elgue, R. Larsson, A. Larsson, S. Thelin, and A. Siegbahn Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 321 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 232 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-F. Chen, W.-C. Tsai, C.-C. Lin, C.-S. Lee, C.-H. Huang, P.-C. Pan, M.-L. Chen, and Y.-S. Huang Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 218 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Scholz, R. Solberg, C. Okkenhaug, V. Videm, M. J Gallimore, O. Mathisen, T. E Mollnes, A. Bergan, O. Soreide, G. B Klintmalm, et al. The significance of heparin-coated veno-venous bypass circuits in liver transplantation Perfusion, January 1, 2002; 17(1): 45 - 50. [Abstract] [PDF]
|
|
|
|
|
|
L.-C. Hsu Heparin-coated cardiopulmonary bypass circuits: current status Perfusion, September 1, 2001; 16(5): 417 - 428. [Abstract] [PDF]
|
|
|
|
|
|
H. Suhara, Y. Sawa, M. Nishimura, H. Oshiyama, K. Yokoyama, N. Saito, and H. Matsuda Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model Ann. Thorac. Surg., May 1, 2001; 71(5): 1603 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Matheis, M Scholz, J Gerber, U Abdel-Rahman, G Wimmer-Greinecker, and A Moritz Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury Perfusion, January 1, 2001; 16(1): 43 - 49. [Abstract] [PDF]
|
|
|
|
|
|
R. Fernando and R. Chan Anti-inflammatory pre-treatment and the resultant effects of interleukin-10: adjuncts to multi-therapeutical strategies Perfusion, December 1, 2000; 15(6): 501 - 505. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Weber, H. P. Wendel, and G. Ziemer Quality Assessment of Heparin Coatings by their Binding Capacities of Coagulation and Complement Enzymes J Biomater Appl, July 1, 2000; 15(1): 8 - 22. [Abstract] [PDF]
|
|
|
|
|
|
R. A. Bronicki, C. L. Backer, H. P. Baden, C. Mavroudis, S. E. Crawford, and T. P. Green Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children Ann. Thorac. Surg., May 1, 2000; 69(5): 1490 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ascione, C. T. Lloyd, M. J. Underwood, A. A. Lotto, A. A. Pitsis, and G. D. Angelini Inflammatory response after coronary revascularization with or without cardiopulmonary bypass Ann. Thorac. Surg., April 1, 2000; 69(4): 1198 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Kozek-Langenecker, S. F. Mohammad, T. Masaki, C. Kamerath, and A. K. Cheung The Effects of Heparin, Protamine, and Heparinase 1 on Platelets in vitro Using Whole Blood Flow Cytometry Anesth. Analg., April 1, 2000; 90(4): 808 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Ilton, P. E. Langton, M. L. Taylor, N. L. A. Misso, M. Newman, P. J. Thompson, and J. Hung DIFFERENTIAL EXPRESSION OF NEUTROPHIL ADHESION MOLECULES DURING CORONARY ARTERY SURGERY WITH CARDIOPULMONARY BYPASS J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 930 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Wendel and G. Ziemer Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 342 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. McCarthy, J.-P. P. Yared, R. C. Foster, D. A. Ogella, J. A. Borsh, and D. M. Cosgrove III A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations Ann. Thorac. Surg., May 1, 1999; 67(5): 1268 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Videm, T. E. Mollnes, E. Fosse, B. Mohr, MD, K. Bergh, T.-A. Hagve, A. O. Aasen, and J. L. Svennevig HEPARIN-COATED CARDIOPULMONARY BYPASS EQUIPMENT. I. BIOCOMPATIBILITY MARKERS AND DEVELOPMENT OF COMPLICATIONS IN A HIGH-RISK POPULATION J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 794 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Videm, T. E. Mollnes, K. Bergh, E. Fosse, B. Mohr, T.-A. Hagve, A. O. Aasen, and J. L. Svennevig HEPARIN-COATED CARDIOPULMONARY BYPASS EQUIPMENT. II. MECHANISMS FOR REDUCED COMPLEMENT ACTIVATION IN VIVO J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Asimakopoulos and K. M. Taylor Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules Ann. Thorac. Surg., December 1, 1998; 66(6): 2135 - 2144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wahba, A. Philipp, R. Behr, and D. E. Birnbaum Heparin-Coated Equipment Reduces the Risk of Oxygenator Failure Ann. Thorac. Surg., May 1, 1998; 65(5): 1310 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Aebert, A. Brawanski, A. Philipp, R. Behr, O.-W. Ullrich, C. Keyl, and D. E. Birnbaum Deep hypothermia and circulatory arrest for surgery of complex intracranial aneurysms Eur. J. Cardiothorac. Surg., March 1, 1998; 13(3): 223 - 229. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
